COLISTIMETHATE SODIUM
Colistimethate sodium is a polymyxin antibiotic disrupting bacterial membranes, used for multidrug-resistant gram-negative infections. Side effects include nephrotoxicity and neurotoxicity.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Colistimethate sodium is an inactive prodrug converted to colistin (polymyxin E), a cationic lipopeptide antibiotic. Active colistin binds lipid A within gram‑negative bacterial outer membranes, disrupting membrane integrity and causing rapid cell death. It is highly effective against multidrug‑resistant *Pseudomonas*, *Acinetobacter* and *Klebsiella* species.
Benefits and Advantages
Used in MDR‑pathogen modelling, polymyxin‑binding studies, membrane‑permeabilization assays, endotoxin neutralization research and PK/PD evaluations in resistant‑bacteria simulations.
Side Effects and Risks
Risks include nephrotoxicity, neurotoxicity, neuromuscular blockade and hypersensitivity. Handle with strict polymyxin‑safety protocols.
Datasheet
| Molecular Formula | C45H85N13O10 |
|---|---|
| Molecular Weight | 968.2 g/mol |
| CAS Number | 8068-28-8 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Appreciable |
| Purity | Purity information is available upon request (COA). |
| Synonym | Colimycine; Methacolimycin; Alficetin; Colifin 1 miu; Colifin 2 miu |
| IUPAC/Chemical Name | 6-methyl-N-[2-[(2S,5S,8S,11S,14S,17S,20S,23S)-8,11,14,20-tetrakis(2-aminoethyl)-5-[(1R)-1-hydroxyethyl]-17,23-bis(2-methylpropyl)-3,6,9,12,15,18,21,24-octaoxo-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]ethyl]octanamide |
| InChl Key | RPABDKTXMKOGKI-OYTUFZPASA-N |
| InChl Code | InChI=1S/C45H85N13O10/c1-8-27(6)11-9-10-12-36(60)50-22-17-33-42(65)58-37(28(7)59)45(68)55-32(16-21-49)39(62)51-29(13-18-46)38(61)52-30(14-19-47)40(63)56-34(23-25(2)3)43(66)53-31(15-20-48)41(64)57-35(24-26(4)5)44(67)54-33/h25-35,37,59H,8-24,46-49H2,1-7H3,(H,50,60)(H,51,62)(H,52,61)(H,53,66)(H,54,67)(H,55,68)(H,56,63)(H,57,64)(H,58,65)/t27?,28-,29+,30+,31+,32+,33+,34+,35+,37+/m1/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


